发明名称 Embolic occlusion of uterine arteries
摘要 A treatment procedure is disclosed which involves the short term, non-permanent occlusion of the patient's blood vessels by depositing a bioabsorbable embolic mass within the patient's blood vessel. The procedure is particularly suitable for treating uterine disorders by occluding a patient's uterine arteries. A therapeutically effective time period for occlusion of a uterine artery is from about 0.5 to about 48 hours, preferably about 1 to about 24 hours, with occlusion times of about 1 to about 8 hours being suitable in many instances. The embolic mass may bioabsorbable particulate with minimum transverse dimensions of about 100 to about 2000 micrometers, preferably about 300 to about 1000 micrometers. The particulate may be a polymeric material formed of polylactic acid, polyglycolic acid or copolymers thereof, or a swellable copolymer of lactic acid and polyethylene glycol. The embolic material may be delivered to an intracorporeal site as a biocompatible solution containing a solute which is relatively insoluble in a water based fluid and a solvent which is relatively soluble in the water based fluid, where the solute forms the embolic mass which occludes or partially occludes a body lumen or fills or partially fills a body cavity.
申请公布号 US2004202694(A1) 申请公布日期 2004.10.14
申请号 US20030411690 申请日期 2003.04.11
申请人 VASCULAR CONTROL SYSTEMS INC 发明人 BURBANK FRED H;ALTIERI GREIG;JONES MICHAEL L
分类号 A61L24/04;(IPC1-7):A61F6/06 主分类号 A61L24/04
代理机构 代理人
主权项
地址
您可能感兴趣的专利